Active — Not RecruitingEarly Phase 1

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

United States65 participantsStarted 2013-04-25

Plain-language summary

This trial studies the use of magnetic resonance imaging (MRI) with Dixon based imaging sequences in detecting prostate cancer. MRI uses radio waves and a powerful magnet linked to a computer to create detailed pictures of areas inside the body. Researchers hope to learn if using a modified MRI scan technique with Dixon based imaging sequencing will help to produce better images of prostate cancer than the standard of care MRI scan technique.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Biopsy proven prostate cancer patients who are scheduled to undergo prostatectomy. * Patient who is scheduled to have a clinically indicated staging endorectal prostate MRI exam. * Patients who have signed their informed consent form to undergo the study. Exclusion Criteria: * Known prior hormone ablation or radiation therapy (pelvic or prostate). * Patients who do not want to undergo prostatectomy and prefer other therapy or surveillance. * Contraindication to conventional MR imaging (e. g. metal implants, pace maker, etc.).

What they're measuring

Detection of at least one or more prostate lesions with Dixon sequencing

Timeframe: through study completion, an average of 1 year

Trial details

NCT IDNCT05047965

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02-02

View on ClinicalTrials.gov More Prostate Carcinoma trials